HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation be enough? new trial aims to reduce side effects for throat cancer patients
Disease control OngoingThis study looks at whether giving a shorter course of lower-dose radiation after robotic surgery is safe for people with HPV-related throat cancer. About 104 adults with early-stage disease will receive this de-intensified treatment. The goal is to keep the cancer from coming ba…
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Disease control OngoingThis study tests whether a much lower dose of radiation (30 Gy) combined with standard chemotherapy works as well as the usual high dose (70 Gy) for people with HPV-positive throat cancer. The goal is to reduce long-term side effects while still controlling the cancer. About 316 …
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo aims to improve head and neck cancer outcomes
Disease control OngoingThis study tests whether adding two drugs, pembrolizumab and olaparib, before and after standard chemoradiation can help control locally advanced head and neck cancer. About 45 adults with this cancer will receive the drug combination. The main goal is to see if this approach imp…
Matched conditions: HPV-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC